Trial Profile
Xtandi® Capsules 40 mg Protocol for Long-Term Specified Drug Use-Results Survey
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 20 Dec 2018 Status changed from active, no longer recruiting to completed.
- 17 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 15 Feb 2016 New trial record